FDA faces backlash over approval of genetic test for opioid addiction risk

The Food and Drug Administration is facing backlash over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction.

Related Keywords

United States ,Columbia University ,New York ,Massachusetts ,Robert Califf ,Andrew Saxon ,Katherine Keyes ,Adam Gordon ,Andrew Kolodny ,Columbia University Mailman School Of Public Health ,Drug Administration ,University Of Utah School Medicine ,Brandeis University ,University Of Washington School Medicine ,Mental Health Services Administration ,Substance Abuse ,Mental Health Services ,Columbia University Mailman School ,Public Health ,Utah School ,Washington School ,